PICO 7 Single Use Negative Pressure Wound Therapy System;PICO 14 Single Use Negative Pressure Wound Therapy System;PICO Fluid Management Packs
Smith and Nephew Medical Limited · Decision date Nov 6, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K263567 on 2026-11-06, covering the PICO 7 Single Use Negative Pressure Wound Therapy System, the PICO 14 Single Use Negative Pressure Wound Therapy System and PICO Fluid Management Packs, submitted by Smith and Nephew Medical Limited. The application was received 09/30/2026 and falls under product code QFC, with OMP listed as a subsequent product code, in the General & Plastic Surgery specialty and review panel. Substantial equivalence is a 510(k) clearance, not a PMA approval.
The record identifies the submission as type Special, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The public listing does not state which components were changed or the basis for equivalence, so the specific modifications and any supporting performance data remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Nov 6, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263567
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Smith and Nephew Medical Limited
- Product code
- QFC
- Decision code
- SESE
- Decision date
- Nov 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Negative Pressure Wound Therapy Device For Reduction Of Wound Complications.
- Applicant
- Smith and Nephew Medical Limited
- Product code
- QFC
- FDA device class
- 2
FDA decision timeline
K263567 received
Application receipt date recorded by FDA.
K263567 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Smith and Nephew Medical Limited
- Headquarters
- Not reported
- Brand website
- smith-nephew.com
- FDA applicant address
- Kingston Upon Hull
Sources and methodology
- Original FDA record: K263567
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records